BFRG BullFrog AI Holdings, Inc. stock chart & analysis
Conviction 53HealthcareScan · Tue, Nov 10, 2026BullFrog AI Holdings, Inc. (BFRG) closed at $0.5512 on Nov 10, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 53, RS Rating 19, -71.9% from its 52-week high, -37.6% year to date. Sector: Healthcare · Pharmaceutical Preparations.
Why BFRG moved
From the StockSetups movers recaps that covered BFRG, newest first. A recap states what was known that day.
- Close+55.0%
The most concrete catalyst on file is insider buying by two senior executives on the same day as the surge. According to Investing.com, CFO Joshua Blacher purchased $26,425 in BFRG stock and CEO Vininder Singh purchased $44,917 — both on September 23.
Top Stock Movers Sept 23, 2026: BENF, WHLR, VSA →
Financials as of Tue, Jun 30, 2026 · quarterly.
BFRG technical analysis
Trend
BFRG's moving averages are mixed — no clean uptrend or downtrend. It closed 0.3% above the 50-day ($0.5495) and 14.8% below the 200-day ($0.6467). ADX(14) at 19 points to a weak trend — more range than direction. It meets 1 of 8 trend-template criteria.
Momentum
RSI(14) is 53, in the bullish half of its range. MACD crossed above its signal line 3 sessions ago. A bullish MACD divergence is in place. Its RS Rating of 19 puts its weighted 12-month performance ahead of about 19% of the US market.
Volume and volatility
It trades about $100,565 a day on average. ATR(14) is $0.0544, 9.9% of price — its typical daily range. Bollinger Bands are in a squeeze (3 sessions) — volatility is compressed. Chaikin Money Flow (-0.06) shows distribution.
Key levels
The chart pattern's support is $0.4625 and its resistance $0.9400. The 52-week range is $0.4251 to $1.96; price is 71.9% below the high and 29.7% above the low. The VWAP anchored at the 52-week high is $1.10, above price.
Performance
BFRG returned +11.0% (1 week), -14.7% (1 month), -5.8% (3 months), -16.1% (6 months), -42.6% (1 year), -37.6% (year to date).
About BullFrog AI Holdings, Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.
Pharmaceutical Preparations · Listed 2023 · 17 employees
SEC filings
EDGAR filings in BFRG · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.